Detect Antimicrobial Resistance

Next-generation technologies to improve workflow and time to results


Antimicrobial Resistance (AMR) is a Global Health Threat

Emerging antibiotic resistance is rising and claims over 700,000 lives per year.1 Antibiotic susceptibility testing plays a crucial role in the patient treatment journey. Ever-evolving regulatory and quality requirements create a constant need for new antibiotics, updated therapeutic guidelines and compliance protocols. Staffing shortages and expanding workloads, paired with increased pressure for accurate and timely results creates an additional burden for the laboratory, whose main goal is to serve as a trusted partner for patient care.

What Drives AMR and Who Does it Affect2?

The main drivers in the development of drug-resistant pathogens are misuse and overuse of antimicrobials in humans, animals, and plants.

AMR impacts countries in all regions
of the world.

Growing AMR makes infections harder to treat and other medical procedures and treatments riskier.



 

“AMR is ever changing….we're getting changing profiles of organisms that are considered to be of risk, and it is all occurring in a One Health system. It isn't just human health, it isn't just veterinary health, it isn't just food and agriculture, it's the whole combination together.”
Professor Elaine Cloutman-Green,
Deputy Director of Infection Prevention
and Control, Great Ormond Street Hospital

Improve Antibiotic Therapy Decisions

We are leveraging our trusted growth-based detection technology and unmatched accuracy to advance the future of antibiotic susceptibility testing. Through our expertise and strategic partnerships, Beckman Coulter is pushing boundaries with next-generation technologies to improve workflow and time to results, enabling laboratories to stay ahead of rising demands.

Together, we are accelerating innovation to improve antimicrobial therapy decisions for every patient.

The DxM MicroScan WalkAway ID/AST system delivers:

  • Trusted detection of emerging and critical AMR with gold-standard MIC accuracy3
  • Enhanced patient care with accurate results
  • Reduced operational burden

DxM Trio

Combine the rapid bacterial identification from the Bruker MALDI with the DxM MicroScan WalkAway and LabPro software for data integration.

Laboratory Automation

Explore our scalable and modular automation solutions for pre-analytical and analytical tasks to streamline your workflow and allow for increased capacity

Together, let’s be part of the solution to AMR and
better patient outcomes.

Schedule a Demo

1. World Health Organization. New report calls for urgent action to avert antimicrobial resistance crisis. Published April 29, 2019. Accessed December 5, 2024 https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis

2. World Health Organization. Antimicrobial resistance. Published November 21, 2023. Accessed December 5, 2024. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

3. Kalorama. United States Market for In Vitro Diagnostic Tests. Page 878. Published July 2016. Accessed December 5, 2024. https://kaloramainformation.com/product/kalorama-2017-ivd-market-research-bundle-the-worldwide-market-for-in-vitro-diagnostic-tests-ngs-companion-us-ivd/

2024-13787